Cephagenix
PrivateLast Round
Seed
Jan 15, 2025
Total Funding Raised
$9.27M
Company Overview
Cephagenix is a drug discovery company that develops novel migraine treatments by identifying and developing selective inhibitors of the ATP-sensitive potassium channel subtype expressed in intracranial arteries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cephagenix Comparables
Compare Cephagenix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Slate Medicines | 78% | |
| Vedana Therapeutics | 71% | |
| H. Lundbeck A/S | 67% |
Cephagenix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 15, 2025 |
Cephagenix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AbbVie Ventures | Seed |
| AdBio partners | Seed |
Cephagenix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cephagenix's valuation, stock price, and market status.
Is Cephagenix a public or private company?
Cephagenix is a private company.
What is the current stock price of Cephagenix?
Cephagenix is a private company with no public stock price. No recent secondary market data is available.
How much is Cephagenix worth (valuation)?
Valuation information for Cephagenix is not publicly available.
Can I buy Cephagenix stock?
Cephagenix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cephagenix's last funding round?
Cephagenix's most recent funding round was Seed on January 15, 2025.
Who are the main investors in Cephagenix?
Key investors in Cephagenix include AbbVie Ventures, AdBio partners.
Will Cephagenix IPO soon?
No public IPO plans have been announced for Cephagenix.
How can I track Cephagenix secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cephagenix's secondary market activity and sign up for updates.